title: Abortion: epidemiology, safety, and technique.
abstract: In 1991, the abortion literature was characterized by articles relating to 1) epidemiologic issues in abortion care, 2) advances in knowledge and experience with medical abortifacients such as mifepristone (RU 486), and 3) cervical ripening prior to abortion with the use of both mifepristone and prostaglandins. Technical methods of achieving termination of pregnancy continue to be similar in the United States, the United Kingdom, and Europe, although induction-abortion times are generally slower in Europe than in the United States. Surgically, dilatation and evacuation procedures continue to be more common in the United States than in other countries. The effectiveness of mifepristone is undisputed, and the recommended dose for early first-trimester termination is being compared with lower dose alternative regimens. There is additional evidence that at least in the short term, the negative psychological sequelae of abortion are infrequent and are inconsequential as a public health issue.
authors.affiliation: Department of Obstetrics and Gynecology, Francis Scott Key Medical Center, Baltimore, MD 21224.
authors.forename: P D
authors.initials: PD
authors.lastname: Blumenthal
mesh_terms: D000027:Abortion, Incomplete / Q000453:epidemiology; D000028:Abortion, Induced / Q000009:adverse effects / Q000379:methods / Q000706:statistics & numerical data; D000031:Abortion, Septic / Q000453:epidemiology; D001291:Attitude of Health Personnel; D001294:Attitude to Health; D002985:Clinical Protocols / Q000592:standards; D004992:Ethics, Medical; D005260:Female; D006291:Health Policy; D006801:Humans; D008428:Maternal Mortality; D015735:Mifepristone / Q000008:administration & dosage / Q000627:therapeutic use; D011247:Pregnancy; D011256:Pregnancy Outcome; D012449:Safety
chemical_list: D015735:Mifepristone